Achieve Life Sciences, Inc. (ACHV)
7.62
-0.22
(-2.81%)
USD |
NASDAQ |
Sep 09, 11:41
Achieve Life Sciences Net Income (Quarterly) : -74.77M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -74.77M |
| March 31, 2026 | -10.17M |
| December 31, 2025 | -14.66M |
| September 30, 2025 | -14.44M |
| June 30, 2025 | -12.72M |
| March 31, 2025 | -12.83M |
| December 31, 2024 | -12.36M |
| September 30, 2024 | -12.51M |
| June 30, 2024 | -8.461M |
| March 31, 2024 | -6.494M |
| December 31, 2023 | -5.476M |
| September 30, 2023 | -7.108M |
| June 30, 2023 | -8.239M |
| March 31, 2023 | -8.992M |
| December 31, 2022 | -11.23M |
| September 30, 2022 | -13.08M |
| June 30, 2022 | -10.47M |
| March 31, 2022 | -7.573M |
| December 31, 2021 | -7.151M |
| September 30, 2021 | -6.691M |
| June 30, 2021 | -11.31M |
| March 31, 2021 | -7.999M |
| December 31, 2020 | -4.724M |
| September 30, 2020 | -3.764M |
| June 30, 2020 | -2.922M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.32M |
| December 31, 2019 | -3.194M |
| September 30, 2019 | -3.673M |
| June 30, 2019 | -3.624M |
| March 31, 2019 | -5.904M |
| December 31, 2018 | -3.637M |
| September 30, 2018 | -3.24M |
| June 30, 2018 | -2.788M |
| March 31, 2018 | -3.022M |
| December 31, 2017 | -3.74M |
| September 30, 2017 | -6.472M |
| June 30, 2017 | -2.997M |
| March 31, 2017 | -3.269M |
| December 31, 2016 | -5.843M |
| September 30, 2016 | -3.69M |
| June 30, 2016 | -6.889M |
| March 31, 2016 | -3.707M |
| December 31, 2015 | -1.724M |
| September 30, 2015 | -4.55M |
| June 30, 2015 | -6.01M |
| March 31, 2015 | -4.517M |
| December 31, 2014 | -5.682M |
| September 30, 2014 | -4.907M |
| June 30, 2014 | -7.015M |
| March 31, 2014 | -8.636M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 3.309M |
| Perspective Therapeutics, Inc. | -26.98M |
| MiMedx Group, Inc. | -14.84M |
| ProText Mobility, Inc. | -0.0155M |
| ABVC BioPharma, Inc. | -0.8105M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 74.77M |
| EPS Diluted (Quarterly) | -0.7996 |
| Enterprise Value | 632.95M |
| Earnings Yield | -20.32% |
| Normalized Earnings Yield | -14.67 |